FindTrial
Sign In

Stereotactic Aspiration for Primary Brainstem Hemorrhage Based on 'Zhe-er Classification'

A Descriptive Research on the Effect of Primary Brainstem Hemorrhage Stereotactic Aspiration Based on 'Zhe-er Classification'

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04910490
Enrollment
340
Registered
2021-06-02
Start date
2020-11-01
Completion date
2021-06-30
Last updated
2021-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Brainstem Hemorrhage

Brief summary

The purpose of this study is to determine the benefit of stereotaxic aspiration for patients with primary brainstem hemorrhage with the guidance of 'Zhe-er Classification'

Detailed description

This is a retrospective study aiming to analyze the clinical record of patients from March 2014 to October 2020. This study is indicated for primary brainstem hemorrhage.

Interventions

OTHERNo interventions - retrospective data collection

No new/additional patients will be enrolled within this project.

Sponsors

Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

no new patients will be enrolled within this project Inclusion Criteria: * Patients undergoing a stereotaxic aspiration or conservative therapy from 3/2014 to 10/2020 in 2nd Affiliated Hospital, School of Medicine, Zhejiang University, China

Exclusion criteria

* patients with secondary brainstem hemorrhage due to blood vessel malformation, trauma, or malignancies

Design outcomes

Primary

MeasureTime frameDescription
Survival events1 year after hemorrhageSurvival events include death, deterioration/recovery of nervous function

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026